MedPath

Sleep Deprivation and Advancement of Sleep Period as Treatment for Bipolar Depression.

Not Applicable
Terminated
Conditions
Bipolar Disorder
Interventions
Behavioral: Sleep deprivation and sleep phase advancement
Other: usual treatment
Registration Number
NCT00229151
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The purpose of this study is to determine if sleep deprivation and sleep phase advancement is effective treatment of bipolar patients in a depressive phase.

Detailed Description

Background: The onset of therapeutic action for most anti-depressive treatments is usually two weeks. During this period patients suffer from great symptomatic distress. Treatment options that are effective in this period is therefore of interest for psychiatric wards.

Aim: To explore if sleep deprivation and three days sleep phase advancement is effective treatment for inpatients with bipolar disorder in a depressive phase.

Method: A randomized controlled trial with 24 patients diagnosed with bipolar disorder. Patients will be randomized to treatment as usual in an psychiatric ward, or sleep deprivation and three days sleep phase advancement. Patients in the treatment as usual group will be offered treatment with sleep deprivation and sleep phase advancement after five weeks if they still meet inclusion criteria.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Bipolar disorder, depressive phase
Exclusion Criteria
  • substance abuse, psychotic symptoms, suicidal intentions, active mania/hypomania.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sleep deprivationSleep deprivation and sleep phase advancementSleep deprivation and sleep phase advancement
usual treatmentusual treatment-
Primary Outcome Measures
NameTimeMethod
Scores on rating scales for depression and symptom severity.one month
Secondary Outcome Measures
NameTimeMethod
Scores on rating scales for anxiety, mania, cognitive processing, and sleep quality.one month

Trial Locations

Locations (1)

Norwegian University of Science and Technology, Institute of Neuroscience

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath